Back
Rocket Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25
RCKT
Rocket Pharmaceuticals
Last Price:
$3.34
Seasonality Move:
23.84%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCKT is experiencing slight buying pressure.
Rocket Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.04 | Buy |
| 20-day SMA: | 2.83 | Buy |
| 50-day SMA: | 3.89 | Sell |
| 200-day SMA: | 9.8 | Sell |
| 8-day EMA: | 2.64 | Buy |
| 20-day EMA: | 1.68 | Buy |
| 50-day EMA: | 0.83 | Buy |
| 200-day EMA: | 0.23 | Buy |
Rocket Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.85 | Buy |
| Relative Strength Index (14 RSI): | 53.58 | Buy |
| Chaikin Money Flow: | 1511420 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.64 - 3.06) | Buy |
| Bollinger Bands (100): | (3.3 - 8.22) | Sell |
Rocket Pharmaceuticals Technical Analysis
| Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rocket Pharmaceuticals Stock
Is Rocket Pharmaceuticals Stock a Buy?
-
Rocket Pharmaceuticals share price is 3.34 while RCKT 8-day simple moving average is 3.04, which is a Buy signal.
-
The stock price of RCKT is 3.34 while Rocket Pharmaceuticals 20-day SMA is 2.83, which makes it a Buy.
-
Rocket Pharmaceuticals 50-day simple moving average is 3.89 while RCKT share price is 3.34, making it a Sell technically.
-
RCKT stock price is 3.34 and Rocket Pharmaceuticals 200-day simple moving average is 9.80, creating a Sell signal.
RCKT Technical Analysis vs Fundamental Analysis
Sell
25
Rocket Pharmaceuticals (RCKT)
is a Sell
Is Rocket Pharmaceuticals a Buy or a Sell?
-
Rocket Pharmaceuticals stock is rated a SellThe current Rocket Pharmaceuticals [RCKT] share price is $3.34. The Score for RCKT is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Rocket Pharmaceuticals Stock Info
Market Cap:
359.8M
Price in USD:
3.34
Share Volume:
12.4M
Rocket Pharmaceuticals 52-Week Range
52-Week High:
26.98
52-Week Low:
2.19
Sell
25
Rocket Pharmaceuticals (RCKT)
is a Sell
Rocket Pharmaceuticals Share Price Forecast
-
What is the Rocket Pharmaceuticals stock price today?The Rocket Pharmaceuticals stock price is 3.34 USD today.
-
Will RCKT stock go up or go down?Rocket Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Rocket Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rocket Pharmaceuticals is overvalued.
Is Rocket Pharmaceuticals Stock a Buy?
-
Rocket Pharmaceuticals share price is 3.34 while RCKT 8-day exponential moving average is 2.64, which is a Buy signal.
-
The stock price of RCKT is 3.34 while Rocket Pharmaceuticals 20-day EMA is 1.68, which makes it a Buy.
-
Rocket Pharmaceuticals 50-day exponential moving average is 0.83 while RCKT share price is 3.34, making it a Buy technically.
-
RCKT stock price is 3.34 and Rocket Pharmaceuticals 200-day simple moving average is 0.23, creating a Buy signal.
Fundamental Analysis of Rocket Pharmaceuticals
Is Rocket Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.16 per share, an increase this year of $0.66 per share, and an increase next year of $0.62 per share.
Technical Analysis of Rocket Pharmaceuticals
Should I short Rocket Pharmaceuticals stock?
-
RCKT Moving Average Covergence Divergence (MACD) indicator is 0.85, suggesting Rocket Pharmaceuticals is a Buy
-
Rocket Pharmaceuticals Relative Strength Index (RSI) is 53.58, which suggest Rocket Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Rocket Pharmaceuticals is (2.64 - 3.06), which suggest Rocket Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Rocket Pharmaceuticals is (3.3 - 8.22), which suggest Rocket Pharmaceuticals is a Sell
* Rocket Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.